SCHEMBL4720749

SCHEMBL4720749

[CH2]CCC1COCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4722099 0.86 CHRM2 (0.44)
SCHEMBL9035179 0.86 CHRM2 (0.35)
SCHEMBL22773777 0.85 CHRM2 (0.42)
SCHEMBL845377 0.80
SCHEMBL202946 0.79
SCHEMBL9109447 0.78
SCHEMBL21766160 0.76
SCHEMBL10305028 0.76
SCHEMBL11603818 0.76
SCHEMBL3166958 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022256299-A1 7-MORPHOLINO-5-(3-PHENYL-1 H-PYRAZOL-1 -YL)-FURO[3,2-B]PYRIDINE DERIVATIVES AND SIMILAR COMPOUNDS AS PIKFYVE KINASE INHIBITORS FOR THE TREATMENT OF E.G. AMYOTROPHIC LATERAL SCLEROSIS (ALS) Verge Analytics, Inc. (US) 2022-12-08 WO claimed
CN-104045599-B The preparation method of 2- amino-3-aryl quinoline 江西师范大学 2019-03-26 CN claimed
CN-104045599-A Preparation method of 2-amino-3-aryl quinoline derivative UNIV JIANGXI NORMAL 2014-09-17 CN claimed
WO-2022256300-A1 FUSED BICYCLIC HETEROCYCLIC COMPOUNDS AND USES THEREOF Verge Analytics, Inc. (US) 2022-12-08 WO disclosed
WO-2022256299-A1 7-MORPHOLINO-5-(3-PHENYL-1 H-PYRAZOL-1 -YL)-FURO[3,2-B]PYRIDINE DERIVATIVES AND SIMILAR COMPOUNDS AS PIKFYVE KINASE INHIBITORS FOR THE TREATMENT OF E.G. AMYOTROPHIC LATERAL SCLEROSIS (ALS) Verge Analytics, Inc. (US) 2022-12-08 WO disclosed
CN-104045599-B The preparation method of 2- amino-3-aryl quinoline 江西师范大学 2019-03-26 CN disclosed
CN-104045599-A Preparation method of 2-amino-3-aryl quinoline derivative UNIV JIANGXI NORMAL 2014-09-17 CN disclosed
CN-102231950-A Releasable polymeric lipids for nucleic acids delivery systems ENZON PHARMACEUTICALS INC 2011-11-02 CN disclosed
CN-102215820-A Releasable Fusogenic Lipids for Nucleic Acid Delivery Systems ENZON PHARMACEUTICALS INC 2011-10-12 CN disclosed
US-20080200475-A1 4-Piperazinothieno[2,3-D] Pyrimidine Compounds As Platelet Aggregation Inhibitors PFIZER INC. 2008-08-21 US disclosed
US-20080194590-A1 4-Piperazinylthieno [2,3-D] Pyrimidine Compounds as Platelet Aggregation Inhibitors PFIZER INC 2008-08-14 US disclosed
WO-2006100591-A1 4-PIPERAZINNYLTHIENO [2,3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS PHARMACIA & UPJOHN COMPANY LLC (US) 2006-09-28 WO disclosed
WO-2006079916-A1 THIENO [2,3-D] PYRIMIDINE COMPOUNDS AS INHIBITORS OF ADP-MEDIATED PLATELETS AGGREGATION PHARMACIA & UPJOHN COMPANY LLC (US) 2006-08-03 WO disclosed
EP-0563328-B1 Tc(III)-99m MYOCARDIAL IMAGING AGENTS AND METHOD OF USE MALLINCKRODT MEDICAL INC (US) 1999-06-30 EP disclosed
US-5541289-A REDUCING A PHOSPHINE SULFIDE TO A PHOSPHINE IN A PEPTIDE WASHINGTON UNIVERSITY (US) 1996-07-30 US disclosed
EP-0563328-A1 ?99m Tc(III) MYOCARDIAL IMAGING AGENTS AND METHOD OF USE MALLINCKRODT MEDICAL, INC. (US) 1993-10-06 EP disclosed
WO-1992011040-A2 99mTc(III) MYOCARDIAL IMAGING AGENTS AND METHOD OF USE MALLINCKRODT MEDICAL, INC. (US) 1992-07-09 WO disclosed
US-5112595-A Diaminoalkyldifuranones and phosphine ligands with technetium for imaging MALLINCKRODT MEDICAL, INC. (US) 1992-05-12 US disclosed
US-5112594-A Diaminoalkyldifuranones and phosphine ligands with technetium for imaging MALLINCKRODT MEDICAL, INC. (US) 1992-05-12 US disclosed
US-4842638-A Herbicidal tetrahydro(thio)pyran-2,4-dione derivatives BASF AKTIENGESELLSCHAFT (DE) 1989-06-27 US disclosed